Rigel Pharmaceuticals
RIGL
RIGL
135 hedge funds and large institutions have $265M invested in Rigel Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.27% less ownership
Funds ownership: 8.87% → 8.6% (-0.27%)
10% less call options, than puts
Call options by funds: $44K | Put options by funds: $49K
Holders
135
Holding in Top 10
–
Calls
$44K
Puts
$49K
Top Buyers
| 1 | +$4.28M | |
| 2 | +$2.94M | |
| 3 | +$2.38M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.02M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.34M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$7.22M | |
| 3 | -$3.48M | |
| 4 |
Morgan Stanley
New York
|
-$2.1M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$2.03M |